[go: up one dir, main page]

ZA200609235B - Specific PPAR agonists for treating negative energy balance - Google Patents

Specific PPAR agonists for treating negative energy balance

Info

Publication number
ZA200609235B
ZA200609235B ZA200609235A ZA200609235A ZA200609235B ZA 200609235 B ZA200609235 B ZA 200609235B ZA 200609235 A ZA200609235 A ZA 200609235A ZA 200609235 A ZA200609235 A ZA 200609235A ZA 200609235 B ZA200609235 B ZA 200609235B
Authority
ZA
South Africa
Prior art keywords
energy balance
ppar agonists
negative energy
treating negative
specific ppar
Prior art date
Application number
ZA200609235A
Other languages
English (en)
Inventor
Kehrli Marcus Eugene Jr
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200609235B publication Critical patent/ZA200609235B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200609235A 2004-05-25 2006-11-06 Specific PPAR agonists for treating negative energy balance ZA200609235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57417104P 2004-05-25 2004-05-25

Publications (1)

Publication Number Publication Date
ZA200609235B true ZA200609235B (en) 2008-08-27

Family

ID=34967765

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609235A ZA200609235B (en) 2004-05-25 2006-11-06 Specific PPAR agonists for treating negative energy balance

Country Status (15)

Country Link
US (1) US20070281935A1 (xx)
EP (1) EP1753426A2 (xx)
JP (1) JP2008500323A (xx)
CN (1) CN1956719A (xx)
AR (1) AR049185A1 (xx)
AU (1) AU2005247164B2 (xx)
BR (1) BRPI0511481A (xx)
CA (1) CA2567398A1 (xx)
IL (1) IL179244A0 (xx)
MX (1) MXPA06013754A (xx)
NO (1) NO20065038L (xx)
RU (1) RU2353362C2 (xx)
TW (1) TWI280879B (xx)
WO (1) WO2005115389A2 (xx)
ZA (1) ZA200609235B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005247172A1 (en) * 2004-05-25 2005-12-08 Pfizer Products Inc. Use of PPAR agonists to treat ruminants
GB0510141D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
ATE496043T1 (de) * 2006-12-01 2011-02-15 Actelion Pharmaceuticals Ltd 3-heteroaryl (amino bzw. amido)-1- (biphenyl bzw. phenylthiazolyl) carbonylpiperdinderivate als orexinrezeptor-inhibitoren
GB0722769D0 (en) * 2007-11-21 2008-01-02 Biolipox Ab New compounds
TW200909417A (en) * 2007-03-12 2009-03-01 Biolipox Ab Piperidinones useful in the treatment of inflammation
DK2370585T3 (en) * 2008-12-02 2016-09-26 Dupont Nutrition Biosci Aps TRIBES AND PRACTICES TO IMPROVE ruminants HEALTH AND / OR -performance
DE102009038123A1 (de) 2009-08-17 2011-02-24 Aicuris Gmbh & Co. Kg Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
CN116162056A (zh) * 2021-11-24 2023-05-26 上海医药工业研究院 β-catenin/BCL9蛋白-蛋白相互作用的小分子抑制剂及其应用
WO2024145931A1 (zh) * 2023-01-06 2024-07-11 上海医药工业研究院有限公司 β-catenin/BCL9蛋白蛋白相互作用的小分子抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
AU683121B2 (en) * 1993-12-23 1997-10-30 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE10238865A1 (de) * 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU2003276596B8 (en) * 2002-11-26 2009-03-05 Pfizer Products Inc. Piperidine compounds useful as PPAR activators
WO2004096139A2 (en) * 2003-04-24 2004-11-11 Incyte Corporation Aza spiro alkane derivatives as inhibitors of metalloproteases
AU2005247172A1 (en) * 2004-05-25 2005-12-08 Pfizer Products Inc. Use of PPAR agonists to treat ruminants

Also Published As

Publication number Publication date
CA2567398A1 (en) 2005-12-08
US20070281935A1 (en) 2007-12-06
AR049185A1 (es) 2006-07-05
CN1956719A (zh) 2007-05-02
WO2005115389A3 (en) 2006-11-16
BRPI0511481A (pt) 2007-12-26
MXPA06013754A (es) 2007-02-08
AU2005247164A1 (en) 2005-12-08
AU2005247164B2 (en) 2008-11-27
IL179244A0 (en) 2007-03-08
TW200607501A (en) 2006-03-01
JP2008500323A (ja) 2008-01-10
EP1753426A2 (en) 2007-02-21
NO20065038L (no) 2006-12-01
RU2006141628A (ru) 2008-05-27
RU2353362C2 (ru) 2009-04-27
WO2005115389A2 (en) 2005-12-08
TWI280879B (en) 2007-05-11

Similar Documents

Publication Publication Date Title
PL1791875T3 (pl) Energoefektywny sposób wytwarzania poliolefin
GB2411178A8 (en) Apparatus for culturing cells
PL1977493T3 (pl) Urządzenie równoważące akumulator
EP2052164A4 (en) PORTABLE HANGER FOR HANDBAGS
AU311450S (en) Charger/holder
GB2418305B (en) Charger
ZA200609235B (en) Specific PPAR agonists for treating negative energy balance
ZA200703293B (en) Cell bandage
EP1713815A4 (en) PTH AGONISTS
GB2430479B (en) Energy controlling device
EP1713782A4 (en) PTH AGONISTS
EP1799653A4 (en) NEW HETEROCYCLES
GB0705300D0 (en) Applicator,kit and process
EP1906132A4 (de) Pistolentasche
GB0701677D0 (en) PCM energy saving device
EP1934431A4 (en) ENERGY TRANSFER MACHINE
EP1788719A4 (en) CELL SEARCH PLANNING METHOD
IL165168A0 (en) Optical concentrator
GB2419427B (en) Mountant solutions
EP1781108A4 (en) USE OF METHYL PYRUVATE FOR INCREASING MUSCLE ENERGY PRODUCTION
GB2412020B (en) Portable charger
GB0424594D0 (en) Energy from waste
GB0502737D0 (en) PCM energy saving device
GB0519874D0 (en) PPAR Agonists II
GB0601559D0 (en) PCM energy saving device